| Literature DB >> 21769565 |
Stavros E Mountantonakis1, Mathew D Hutchinson.
Abstract
Dramatic reductions in the rate of sudden cardiac death due to use of implantable cardioverter-defibrillators (ICDs) have been well-established in several large randomized clinical trials including patients with left ventricular dysfunction after myocardial infarction. This article reviews the literature regarding ICD utilization in the postinfarction population, with a strong emphasis on recent clinical trials. The most current indications for, and timing of, ICD implantation postinfarction also are summarized.Entities:
Mesh:
Year: 2011 PMID: 21769565 DOI: 10.1007/s11897-011-0069-1
Source DB: PubMed Journal: Curr Heart Fail Rep ISSN: 1546-9530